These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25554804)

  • 61. [SLE, progressive systemic sclerosis, polymyositis, MCTD and the vascular lesions].
    Hashimoto H; Hirose S
    Nihon Rinsho; 1985 Oct; 43(10):2070-6. PubMed ID: 3912534
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan.
    Kotajima L; Aotsuka S; Sumiya M; Yokohari R; Tojo T; Kasukawa R
    J Rheumatol; 1996 Jun; 23(6):1088-94. PubMed ID: 8782145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiac involvement in mixed connective tissue disease. A fatal case of scleroderma combined with systemic lupus erythematosus.
    Przybojewski JZ; Mynhardt JH; van der Walt JJ; Tiedt FA
    S Afr Med J; 1985 Oct; 68(9):680-6. PubMed ID: 4060033
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.
    Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Mahler M; Fritzler MJ; Bossuyt X
    Autoimmun Rev; 2018 Jun; 17(6):533-540. PubMed ID: 29526634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Mixed connective tissue diseases or systemic lupus erythematosus?].
    Kuch J; Mazurek K; Serwecińska T
    Wiad Lek; 1978 Aug; 31(16):1163-7. PubMed ID: 706371
    [No Abstract]   [Full Text] [Related]  

  • 66. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Some progress with systemic sclerosis.
    Abruzzo JL
    Ann Intern Med; 1979 Jan; 90(1):117-8. PubMed ID: 420441
    [No Abstract]   [Full Text] [Related]  

  • 68. What's in a name? That which we call a rose by any other name would smell as sweet.
    Sundt TM
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):e323. PubMed ID: 30797589
    [No Abstract]   [Full Text] [Related]  

  • 69. Disease Labels and Clear Communication With Patients-A Rose by Any Other Name Would Smell as Sweet.
    Kohn EC; Malik S
    JAMA Oncol; 2019 Jun; 5(6):784-785. PubMed ID: 30896753
    [No Abstract]   [Full Text] [Related]  

  • 70. Would a Rose by Any Other Name Really Smell as Sweet? Framing Our Work in Infection Prevention.
    Summerlin-Long SK; Weber DJ; DiBiase LM; Buchanan MO; Sickbert-Bennett EE;
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):1010-1011. PubMed ID: 29909822
    [No Abstract]   [Full Text] [Related]  

  • 71. A rose by any other name would smell as sweet † ; does nomenclature matter?
    Lanzer P; Sato Y; Virmani R
    Eur Heart J; 2022 Aug; 43(30):2824-2826. PubMed ID: 35695700
    [No Abstract]   [Full Text] [Related]  

  • 72. Epilepsy by Any Other Name Would (Not!) Smell as Sweet.
    Stafstrom CE
    J Pediatr; 2017 Dec; 191():8-9. PubMed ID: 29033243
    [No Abstract]   [Full Text] [Related]  

  • 73. Definitions and usage, or a rose by any other name smells as sweet.
    Salzinger K
    Behav Anal; 1991; 14(2):213. PubMed ID: 22478102
    [No Abstract]   [Full Text] [Related]  

  • 74. "A rose by any other name": does defining extreme phenotypes add to the management of multiple sclerosis?
    Jolliffe EA; Weinshenker BG
    Ann Transl Med; 2018 Oct; 6(20):396. PubMed ID: 30498724
    [No Abstract]   [Full Text] [Related]  

  • 75. Systemic sclerosis: Recent insights.
    Elhai M; Avouac J; Kahan A; Allanore Y
    Joint Bone Spine; 2015 May; 82(3):148-53. PubMed ID: 25557659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic sclerosis in 2014: Advances in cohort enrichment shape future of trial design.
    Allanore Y; Distler O
    Nat Rev Rheumatol; 2015 Feb; 11(2):72-4. PubMed ID: 25561368
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
    Arthritis Rheum; 1980 May; 23(5):581-90. PubMed ID: 7378088
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Digital ulcers predict a worse disease course in patients with systemic sclerosis.
    Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2016 Apr; 75(4):681-6. PubMed ID: 25688073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.